Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study to bowel cleansing evaluation of mixed two other type bowel preparation drug(PICOLIGHT plus COOLPREP, PICOLIGHT plus CLICOLON).
To evaluate mixed-drug bowel preparation methods for decreasing side effect and increasing compliance
Picolight + Coolprep [Day-Prior] Picolight + Clicolon [Day-Prior] Picolight + Coolprep [Split-Dose] Picolight + Clicolon [Split-Dose]
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Picolight + Coolprep (Day-Prior) | Active Comparator | Picolight (1p/250cc, 5PM) + Coolprep (500cc x 2, 8PM)[Day-Prior] |
|
| Picolight + Clicolon (Day-Prior) | Active Comparator | Picolight (1p/250cc, 5PM) + Clicolon (4T x 4, 8PM) [Day-Prior] |
|
| Picolight + Coolprep (Split-Dose) | Active Comparator | Picolight (1p/250cc, 7PM) + Coolprep (500cc x 2, 5AM)[Split-Dose] |
|
| Picolight + Clicolon (Split-Dose) | Active Comparator | Picolight (1p/250cc, 7PM) + Clicolon (4T x 4, 5AM)[Split-Dose] |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Picolight + Coolprep | Drug | Picolight (1p/250cc, 5PM) + Coolprep (500cc x 2, 8PM)[Day-Prior] Picolight (1p/250cc, 7PM) + Coolprep (500cc x 2, 5AM)[Split-Dose] |
|
| Measure | Description | Time Frame |
|---|---|---|
| Bowel preparation quality | Aronchick bowel preparation score; Excellent: small volume of clear liquid or greater than 95% of surface seen Good: large volume of clear liquid 5% to 25% of the surface but greater than 90% of surface seen Fair: some semi-solid stool that could be suctioned or washed away, but greater than 90% of surface seen Poor: semi-solid stool that could not be suctioned or washed away and less than 90% of surface seen Inadequate: re-preparation needed (* 'success' of bowel preparation is defined as Aronchick's 'Excellent' or 'Good'.) | the day of colonoscopy |
| Measure | Description | Time Frame |
|---|---|---|
| Patient tolerance | Patient's tolerance; 1= "none"; 2= "mild"; 3= "bothersome"; 4= "distressing"; 5= "severely distressing" | the day of colonoscopy |
| Measure | Description | Time Frame |
|---|---|---|
| Adenoma detection rate | Adenoma detection rate (%) | The day of colonoscopy |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dae Kyung Sohn | NCC,Korea | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dae Kyung Sohn | Goyang-si | Gyeonggi-do | 410-769 | South Korea |
Not provided
| ID | Term |
|---|---|
| D008277 | Magnesium Oxide |
| C005701 | picosulfate sodium |
| C012036 | sodium sulfate |
| ID | Term |
|---|---|
| D017616 | Magnesium Compounds |
| D007287 | Inorganic Chemicals |
| D010087 | Oxides |
| D017601 | Oxygen Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Picolight + Clicolon | Drug | Picolight (1p/250cc, 5PM) + Clicolon (4T x 4, 8PM) [Day-Prior] Picolight (1p/250cc, 7PM) + Clicolon (4T x 4, 5AM)[Split-Dose] |
|
|